Cyclosporine vs Durvalumab

Cyclosporine vs Durvalumab: Overview

This comparison examines the pharmacological differences between Cyclosporine and Durvalumab.

Mechanism of Action

Cyclosporine: Calcineurin inhibitor suppressing T-cell activation.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Cyclosporine — 6-12 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Cyclosporine — C62H111N11O12.

Molecular Weight: Cyclosporine — 1202.6100 g/mol.

Type: Cyclosporine — Protein; Durvalumab — Antibody.